• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe

Regulatory/Compliance

FDA | Recalls | 510(k) | Pre-Market Approvals | MDSAP | Clinical Trials

Boston Scientific recalls spinal cord stimulator leads after 1,081 serious injuries

September 4, 2026 By Skyler Rivera

Boston Scientific recalled all unused Infinion CX leads used in its spinal cord stimulator systems (SCS) after identifying an issue that could result in “high impedance measurements or lead fractures,” the company said. The company said the lead body could experience mechanical stress at the anchor site, which could cause the abnormal impedance measurements or […]

Filed Under: Featured, Food & Drug Administration (FDA), Implants, Pain Management, Recalls, Regulatory/Compliance, Spine Tagged With: Boston Scientific, spinal cord stimulation

Globus Medical wins CE mark for Excelsius3D imaging system

September 4, 2026 By Chris Newmarker

Globus Medical (NYSE: GMED) has secured a CE mark for its Excelsius3D intelligent 3-in-1 imaging system for spine and cranial procedures. The regulatory approval in the EU, announced yesterday, comes five years after the system’s FDA clearance in the U.S. With a CE mark, Audubon, Pennsylvania–based Globus kicks off commercialization of Excelsius3D in the European […]

Filed Under: Neurological, Orthopedics, Regulatory/Compliance, Spine Tagged With: CE Mark, Globus Medical

Medtronic says Endurant stent graft’s new CE mark could boost use for ruptured AAA

September 4, 2026 By Chris Newmarker

Medtronic (NYSE: MDT) has secured a CE mark for its Endurant stent graft, removing a treatment warning related to its use in ruptured abdominal aortic aneurysms (AAA). The Minnesota-run medtech giant received a similar FDA labeling change in late 2025. A ruptured AAA occurs when the main artery in the abdomen bursts, causing severe internal […]

Filed Under: Cardiovascular, Featured, Regulatory/Compliance, Stents Tagged With: CE Mark, Medtronic, nitinol

Boston Scientific recalls, discontinues angiographic catheter sales

September 2, 2026 By Skyler Rivera

Boston Scientific recalled and discontinued all Imager II angiographic catheters due to a manufacturing issue, according to an FDA early alert. Imager II angiographic catheters are diagnostic intravascular catheters used to capture images of the patient’s peripheral vasculature. Boston Scientific determined the catheters were “manufactured with reduced levels of stabilizing agents in the tips,” according […]

Filed Under: Business/Financial News, Catheters, Diagnostics, Featured, Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance, Vascular Tagged With: Boston Scientific, catheter, recall

MicroPort’s covered stent system receives special review in China

September 2, 2026 By Julia Rock-Torcivia

MicroPort Coronary announced that its FireShield coronary covered stent system will undergo the National Medical Products Administration (NMPA) special review procedures in China. The special review procedures aim to accelerate review for innovative medical devices that meet criteria for domestic originality, technical novelty and clinical value. (The FDA Investigational Device Exemption program plays a similar […]

Filed Under: Cardiovascular, News Well, Regulatory/Compliance, Stents Tagged With: MicroPort, National Medical Products Administration

GE HealthCare’s Photonova Spectra system receives CE mark 

September 1, 2026 By Julia Rock-Torcivia

GE HealthCare announced it has received the CE Mark for its Photonova Spectra system, a photon-counting computed tomography (PCCT) system integrated with the company’s Deep Silicon detector technology. The system provides on-demand spectral and spatial imaging for every scan, and its ultra-high definition (UHD) imaging is “designed to work with wide coverage,” the company said. […]

Filed Under: Imaging, News Well, Regulatory/Compliance Tagged With: CE Mark, GE Healthcare

MiniMed wins CE mark for next-gen insulin pump, ups revenue guidance

September 1, 2026 By Chris Newmarker

MiniMed (Nasdaq: MMED) today reported Street-beating first-quarter revenue, upping its full-year sales guidance as it notched an early European regulatory win. The Northridge, California–based diabetes tech company, spun out of Medtronic earlier this year, announced a CE mark for its next-gen, app-controlled MiniMed Flex insulin pump — well ahead of the company’s calendar 2026 year-end target. […]

Filed Under: Business/Financial News, Diabetes, MassDevice Earnings Roundup, Regulatory/Compliance, Wall Street Beat Tagged With: CE Mark, insulin pump, MiniMed

Medtronic recalls reflux testing system after 184 serious injuries

August 31, 2026 By Skyler Rivera

Medtronic initiated a global voluntary recall for certain lots of its Bravo calibration-free (CF) reflux testing system after reports of 184 serious injuries associated with a deployment control problem. Medtronic recalled the device “due to a risk of attachment and detachment issues related to the system’s delivery system,” a Medtronic spokesperson told MassDevice. “To ensure […]

Filed Under: Diagnostics, Endoscopic, Featured, Food & Drug Administration (FDA), News Well, Patient Monitoring, Recalls, Regulatory/Compliance Tagged With: Covidien, FDA, Given Imaging, Medtronic, recall

Johnson & Johnson’s Abiomed recalls Automated Impella Controllers after 3 patient deaths

August 27, 2026 By Skyler Rivera

Johnson & Johnson’s Abiomed recommends customers remove all Automated Impella Controllers (AICs) from where they’re used or sold after 37 reports of serious injuries and three deaths were linked to component failures. Abiomed identified purge cassette recognition issues “resulting from failures of the purge flag component within the purge pressure sensor assembly.” J&J issued the […]

Filed Under: Cardiovascular, Catheters, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Structural Heart, Structural Heart Tagged With: Abiomed, Impella, Johnson & Johnson, Johnson & Johnson MedTech

Paradromics gets FDA nod to expand BCI compatibility to personal devices

August 27, 2026 By Skyler Rivera

Paradromics received FDA approval to expand the types of computing devices that could be used with its investigational brain-computer interface (BCI) system, the company told MassDevice. “This FDA approval clears a path for our software to work on the everyday devices people already rely on – laptops, tablets, phones – so that a brain-computer interface […]

Filed Under: Biotech, Brain-Computer Interface (BCI), Business/Financial News, Featured, Food & Drug Administration (FDA), Implants, Neurological, Regulatory/Compliance, Research & Development, Surgical Tagged With: brain-computer interface, FDA, paradromics

Abbott’s next-generation Amulet LAA occlusion device earns CE Mark

August 27, 2026 By Skyler Rivera

Abbott’s (NYSE: ABT) Amulet 360 left atrial appendage (LAA) occlusion device received CE mark, the company announced today. The next-generation minimally invasive device is designed to reduce the risk of stroke in patients with non-valvular atrial fibrillation (AFib) by helping seal the LAA of the patient’s heart. Amulet 360 features a redesigned dual-seal technology that […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Featured, Implants, Regulatory/Compliance, Structural Heart, Structural Heart, Surgical Tagged With: Abbott, CE Mark, Electrophysiology, LAAO devices, nitinol

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 861
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy